Close Menu

functional genomics

The ROS1ders advocacy group is 500 patients strong and they are helping researchers establish cell lines to improve understanding of rare ROS1-positve cancers. 

The researchers aimed to develop a test that could help clinicians determine whether a patient would respond to therapy, before the onset of treatment.